Skip to main content
  • Original Paper
  • Published:

Detection of dihydropyridine- and voltage-sensitive intracellular Ca2+ signals in normal human parathyroid cells

Abstract

We recently showed dihydropyridine- and voltage-sensitive Ca2+ entry in cultured parathyroid cells from patients with secondary hyperparathyroidism. To determine whether normal parathyroid cells have a similar extracellular Ca2+ entry system, cells were isolated from normal (non-hyperplastic) human parathyroid glands. Fluorescence signals related to the cytoplasmic Ca2+ concentration ([Ca2+]I) were examined in these cells. Cells loaded with fluo-3/AM showed a transient increase in fluorescence (Ca2+ transient) following a 10-s exposure to a 150 mM K+ solution in the presence of millimolar concentrations of external Ca2+. The Ca2+ transient was reduced by dihydropyridine antagonists or 0.5 mM Cd2+, but enhanced by FPL-64176, an L-type Ca2+-channel agonist. Ca2+ transients induced by the 10-s exposure to 3.0 mM extracellular Ca2+ ([Ca2+]o) were also inhibited by dihydropyridine antagonists or 0.5 mM Cd2+. These results provide the first evidence that normal human parathyroid cells express a dihydropyridine-sensitive Ca2+ entry system that may be involved in the [Ca2+]o-induced change in [Ca2+]I. This system might provide a compensatory pathway for negative feedback regulation of parathyroid hormone secretion under physiological conditions.

Introduction

The serum (extracellular) Ca2+ concentration ([Ca2+]o) is tightly controlled through negative feedback regulation by parathyroid hormone (PTH) secretion from the parathyroid gland. By targeting bones, kidneys and the small intestine, PTH leads to elevated [Ca2+]o. PTH secretion increases with decreasing [Ca2+]o and vice versa [1, 2]. The cytoplasmic Ca2+ concentration ([Ca2+]I) in parathyroid cells is the key determinant of PTH secretion as indicated in studies on cultured bovine parathyroid cells showing that changes in [Ca2+]I occur in parallel with changes in [Ca2+]o [3, 4].

It is well established that signaling information from [Ca2+]o is transduced to [Ca2+]I via the Ca2+-sensing receptor (CaR), a G protein-coupled transmembrane protein that is abundantly expressed in the surface membrane of parathyroid cells [5, 6] and other cell types [2]. The current view of this process is that CaR transduces [Ca2+]o into [Ca2+]I by regulating the amount of Ca2+ released from intracellular Ca2+ stores. This mechanism is supported by findings that inositol 1,4,5-trisphosphate (IP3) production is increased in bovine parathyroid cells in the presence of relatively high [Ca2+]o, and that HEK-293 cells exhibit IP3-induced Ca2+ release when transfected with a plasmid carrying cDNA for CaR [7].

In addition to the IP3-mediated mechanism, the results from several studies suggest that dihydropyridine-sensitive Ca2+ entry participates in the regulation (negative feedback) of PTH secretion [812] and [Ca2+]I [11, 1315]. We recently directly detected dihydropyridine- and voltage-sensitive Ca2+ entry in cultured parathyroid cells from patients with secondary hyperparathyroidism [16], thereby raising the question of whether such a Ca2+ entry system is a feature of normal parathyroid cells. The aim of the study reported here was to isolate parathyroid cells from normal (non-hyperplastic) parathyroid glands and to detect extracellular Ca2+ entry using fluo-3, a Ca2+-sensitive fluorescent indicator dye.

Materials and methods

Ethical approval

The study follows procedures that are in accordance with the Helsinki Declaration of 1983 and which were approved by the Ethics Committee of Jikei University School of Medicine. Written informed consent was obtained from all three patients prior to surgery. In all cases, the removal of normal parathyroid glands was performed for therapeutic purposes and was not related in any way to the goals of this study.

Cell preparation

Cultured normal parathyroid cells were prepared essentially as described by Yokoyama et al. [16], although the isolation procedure for extremely small normal parathyroid glands was more difficult than that developed for large parathyroid glands in patients with secondary hyperparathyroidism. Normal parathyroid glands (diameter 5 mm) were surgically removed from patients with thyroid cancer and stored for 2–6 h in cold (<4 °C) culture medium [Dulbecco’s modified Eagle’s medium (DMEM; GIBCO BRL, Gaithersburg, MD) supplemented with 10 % heat-inactivated fetal bovine serum (FBS; JRH Biosciences, Lenexa, KS/Thermo Trace, Noble Park, Victoria, Australia), 1 mM Na+ pyruvate (Sigma, St. Louis, MO) and penicillin/streptomycin (100 U/ml; GIBCO BRL)]. Following removal of fat and connective tissues, the parathyroid glands were minced finely (fragments <0.3 mm) with scissors in ice-cold HEPES buffer solution containing 146 mM NaCl, 5.0 mM KCl, 1.0 mM CaCl2, 0.5 mM MgCl2, and 10 mM HEPES, adjusted to pH 7.4 with NaOH. Digestion with 2 mg/ml collagenase (Sigma Type IA) was carried out for 50–60 min in a water bath shaker (130–140 cpm; TAITEC, Kubota, Japan) at 37 °C. The turbid solution was sedimented for 10 min in a centrifuge (KN-70; TAITEC) at 700–1000 rpm. Isolated cells plated on sterilized gelatin-coated glass cover slips (diameter 14 mm; thickness 0.08–0.12 mm; Matsunami Glass, Osaka, Japan) were cultured for 36–74 h in culture medium and incubated at 37 °C in a humidified atmosphere of 95 % air and 5 % CO2. In two patients from whom normal (non-hyperplastic) parathyroid glands were surgically removed, the serum levels of intact PTH were 39 and 58 pg ml−1. These values fall within the normal range of serum PTH (10–65 pg ml−1) in healthy adults. In patients with secondary hyperparathyroidism, the serum PTH was 180.0 ± 13.1 pg ml−1 [16].

Fluorescence measurements

Changes in [Ca2+]I were estimated with a Ca2+-sensitive fluorescent indicator, as described previously [16]. Cultured parathyroid cells were loaded for 40–60 min with fluo-3/AM at a final concentration of 10 µM (Invitrogen, Carlsbad, CA) at 37 °C in a standard bath solution containing 146 mM NaCl, 1.5 or 2.0 mM CaCl2, 5.0 mM KCl, 1.0 mM MgCl2 and 10 mM HEPES, adjusted to pH 7.4 with NaOH. One part of pluronic acid was added to five parts of dye dissolved in dimethyl sulfoxide (DMSO) before final dilution with saline. Preliminary experiments revealed that >90 % of the baseline fluorescence signal reflected [Ca2+]I [16]. Fluorescence was detected with a modified Nipkow laser high-speed confocal scanning microscope system (CSU-21; Yokogawa Electric, Tokyo, Japan) attached to an inverted microscope (model IX70; Olympus, Tokyo, Japan). The excitation light was emitted from a laser unit (488 nm; argon laser, 4–13 mW). The light passing through the pinholes was focused by an objective lens (UPlanFl 40×, NA = 0.75; Olympus) to a point on the cells. Fluorescent light beams emitted from a cluster of cells were scanned by the pinholes and reflected by a dichroic mirror, passed through a barrier filter (>515 nm) and captured by a cooled digital EMCCD camera (C9100-12; Hamamatsu Photonics, Hamamatsu, Japan). Two-dimensional images composed of 512 × 512 pixels (204.8 µm × 204.8 µm) were recorded at 2 frames/s−1 with an exposure time of 495 ms. Data acquisition and image analysis were carried out on an IBM computer using the Aquacosmos image program (Hamamatsu Photonics); for details, see Yokoyama et al. [16]. All experiments were carried out at room temperature. A high K+ solution or 3 mM Ca2+ was applied by local ejection from a small-tipped pipette using a pressure ejection device (PicoPump; World Precision Instruments, Sarasota, FL). The high K+ solution contained 150 mM KCH3O3S (potassium methane sulfonate), 1.5 or 2.0 mM CaCl2, 1.0 mM MgCl2, and 10 mM HEPES, adjusted to pH 7.4 with KOH. Changes in fluorescence from the cytoplasm (excluding the nucleus) are shown relative to the baseline fluorescence (∆F/F), where F is the baseline fluorescence and ∆F is the change in fluorescence in response to stimulation. Background intensity was subtracted from the raw data before calculating ∆F/F. Results are reported as the mean ± standard deviation (SD). In the experiments using 1 µM dihydropyridine antagonists, cells were pretreated with these agents for >25 min because the dihydropyridine-binding domains are not easily accessible at relatively hyperpolarized membrane potentials [17, 18].

Results

Voltage-dependent activation of the transient increase in fluorescence

We first examined whether depolarization evokes Ca2+ entry in cultured normal parathyroid cells. Cells were loaded with fluo-3/AM, and the surface membrane was depolarized to close to 0 mV (assuming a cytoplasmic K+ concentration of about 140 mM) by external exposure to a 150 mM K+ solution. A transient increase in fluo-3 fluorescence (Ca2+ transient) was detected in most cells following a 10-s exposure to the 150 mM K+ solution containing 2 mM Ca2+ (n > 74 cells from 3 patients), indicating that a transient increase in [Ca2+]I occurred in response to membrane depolarization (Fig. 1, left). We gently applied the solution from a small-tipped pipette to avoid opening mechanosensitive channels, resulting in slow onset of the Ca2+ transient following pressure application.

Fig. 1
figure 1

Voltage-dependent activation of a transient increase in fluo-3 Ca2+ transients in a normal parathyroid cell. Left Application of a 150 mM K+ solution (2 mM Ca2+) evoked a transient increase in fluo-3 fluorescence (Ca2+ transient). Right Application of a nominally Ca2+-free 150 mM K+ solution failed to increase fluo-3 fluorescence. F Baseline fluorescence, ∆F change in fluorescence in response to stimulation

In a similar manner, nominally Ca2+-free saline containing 150 mM K+ was gently applied to targeted cells. However, depolarization failed to evoke a Ca2+ transient in the absence of [Ca2+]o (Fig. 1, right; n = 10). Before application of nominally Ca2+-free saline, the bath was switched to a 1 mM [Ca2+]o solution to reduce [Ca2+]o in the vicinity of the targeted cells; the average amplitude of fluo-3 fluorescence decreased significantly from 3.37 ± 1.16 to 0.17 ± 0.08 (n = 10). Application of the bath solution per se did not induce a Ca2+ transient (n = 8).

The high K+-induced Ca2+ transient is sensitive to L-type Ca2+ channel modulators

We then examined whether Ca2+ entry is sensitive to L-type Ca2+ channel modulators. As shown in Fig. 2a, the depolarization-induced Ca2+ transient in 1.2–1.5 mM [Ca2+]o markedly increased in the presence of 10 µM FPL-64176 (n = 10), a potent agonist of L-type Ca2+ channels that is known to bind to a domain distinct from that of dihydropyridines and exhibits exclusive Ca2+-channel agonist action, even at very high concentrations [19, 20]. In contrast, exposure to the high K+ solution failed to induce a noticeable Ca2+ transient following treatment with 1 µM nicardipine for >25 min (Fig. 2b). The high K+-induced Ca2+ transient was also strongly inhibited by 0.5 mM Cd2+ (n = 21). The effects of L-type Ca2+ channel modulators on fluo-3 fluorescence in response to the high K+ solution are summarized in Table 1. Taken together, these results suggest that normal parathyroid cells of human origin express an extracellular Ca2+ entry system that is physiologically similar to L-type Ca2+ channels.

Fig. 2
figure 2

The high K+-induced Ca2+ transient is sensitive to L-type Ca2+ channel modulators. a The bath contained 1.2 mM Ca2+ to highlight the effect of the agent. Left Application of a 150 mM K+ solution caused a small increase in fluo-3 fluorescence. Right In the presence of FPL-64176, fluo-3 fluorescence was markedly increased upon exposure to the high K+ solution. b Left In the absence of nitrendipine, application of a 150 mM K+ solution evoked a transient increase in fluo-3 fluorescence. The bath contained 2 mM Ca2+. Right In the presence of 1 µM nitrendipine, exposure to the high K+ solution failed to increase fluo-3 fluorescence

Table 1 Effect of Ca2+ channel modulators on the Ca2+ transient induced by extracellular application of 150 mM K+ or 3 mM Ca2+

Inhibition of the high [Ca2+]o-induced Ca2+ transient by Ca2+ channel inhibitors

Finally, we investigated the effects of L-type Ca2+ channel inhibitors on the high [Ca2+]o-induced increase in [Ca2+]I. This was a characteristic feature of the parathyroid cells in which [Ca2+]o was ≥2.5 mM was able to induce this type of response under our experimental conditions. As shown in Fig. 3a (left), external application of the 3 mM [Ca2+]o solution to cells bathed in 2 mM [Ca2+]o solution evoked a transient increase in fluo-3 fluorescence. This did not occur following treatment with 1 µM nitrendipine for >25 min (Fig. 3a, right). In this population, all cells tested showed >95 % abrogation of the 3 mM [Ca2+]o-induced Ca2+ transient (n = 20). Similar inhibitory effects were obtained with 1 µM nicardipine (n = 20). The high [Ca2+]o-induced Ca2+ transient was also strongly inhibited by 0.5 mM Cd2+ (n = 12). The effects of L-type Ca2+ channel modulators on fluo-3 fluorescence in response to the 3 mM [Ca2+]o solution are summarized in Table 1.

Fig. 3
figure 3

Reduction of the high serum (extracellular) Ca2+ concentration ([Ca2+]o)-induced Ca2+ transient by L-type Ca2+ channel inhibitors. The bath contained 2 mM Ca2+. a Application of the 3 mM [Ca2+]o solution for 10 s evoked a Ca2+ transient (left). Following treatment with 1 µM nicardipine for >25 min, application of the 3 mM [Ca2+]o solution no longer induced a Ca2+ transient (right). b In the presence of 0.5 mM Cd2+, application of 3 mM [Ca2+]o solution also failed to induce a Ca2+ transient (right)

Discussion

In this study, we detected dihydropyridine-sensitive extracellular Ca2+ entry in normal parathyroid cells of human origin. The results in Fig. 1 suggest that the 150 mM K+-induced Ca2+ transient observed in the presence of millimolar [Ca2+]o reflects Ca2+ entry through voltage-dependent Ca2+ channels and that a high K+ per se is not the cause of Ca2+ release from the endoplasmic reticulum via direct activation of the CaR. The fluorescence measurements in Fig. 2 and Table 1 further indicate that voltage-activated extracellular Ca2+ entry is sensitive to L-type Ca2+ channel modulators. Thus, voltage-sensitive Ca2+ entry appears to be an essential feature of normal parathyroid cells. These results are compatible with previous findings in patients with secondary hyperparathyroidism [16]. The Ca2+ transient induced by 150 mM K+ was inhibited by 1 µM nitrendipine (from 3.0 ± 1.2 to 0.3 ± 0.3, n = 19), 1 µM nicardipine (from 2.8 ± 1.5 to 0.4 ± 0.6, n = 18), and 0.5 mM Cd2+ (from 2.6 ± 1.4 to 0.6 ± 0.7, n = 10)[16]. It should be noted that nearly complete abrogation was frequently observed in both populations. In contrast, FPL-64176 enhanced the depolarization-induced Ca2+ transient in parathyroid cells from patients with secondary hyperparathyroidism (from 2.7 ± 1.2 to 4.4 ± 1.6, n = 10) [16].

The cultured normal parathyroid cells were only exposed to excitation light during fluorescence measurements to reduce inactivation of the agents nitrendipine and nicardipine used in the study. Furthermore, both of these agents are resistant to light illumination, even at shorter wavelengths [18]. These features of the experiments are important, since earlier reports refuting dihydropyridine-sensitive Ca2+ entry in normal parathyroid cells did not address these points.

It would appear that the data presented in Fig. 3 and Table 1 support the previously proposed idea that dihydropyridine-sensitive Ca2+ entry is involved in regulation of [Ca2+]I by [Ca2+]o [16]. In cells from patients with secondary hyperparathyroidism, the Ca2+ transient induced by 3 mM [Ca2+]o was also strongly inhibited by 1 µM nitrendipine (from 4.88 ± 2.6 to 0.15 ± 0.09, n = 20) and 0.2 mM Cd2+ (from 3.9 ± 1.1 to 0.44 ± 0.60, n = 20). Furthermore, extracellular application of 3 mM [Ca2+]o or 150 mM K+ solution failed to induce a noticeable Ca2+ transient just (e.g. 15 s) following the preceding 30 s exposure to the 150 mM K+ solution. After a 10 min rest, however, the 3 mM [Ca2+]o or 150 mM K+ solution was again able to induce a Ca2+ transient with nearly the same amplitude (Figs. 2 and 6 in [16]). These results suggest that the cell had not deteriorated, but experienced a voltage-dependent inactivation process. This type of experiment was not conducted in the present study.

The mechanism through which voltage-dependent Ca2+ entry is activated under physiological conditions remains to be elucidated. The resting membrane potentials of normal parathyroid cells are more negative than −60 mV in the presence of physiological [Ca2+]o [21, 22], and thus the membrane requires depolarization for voltage-dependent Ca2+ channels to be effectively opened. It is possible that activation of CaR by extracellular Ca2+ causes an increase in [Ca2+]I via the IP3-mediated pathway, which in turn inhibits Ca2+-activated K+ channels that may have a high affinity for Ca2+, resulting in mild depolarization of the surface membrane [21, 23, 24]. Extracellular Ca2+ entry per se may further depolarize the membrane. Nevertheless, Ca2+-activated K+ channels with a low affinity for Ca2+ may compete with this effect [2325], resulting in a relatively mild and slow membrane potential change during exposure to high [Ca2+]o [21, 22]. It is also possible that the CaR directly or indirectly activates Ca2+ entry without causing a significant membrane potential change. Alternatively, window Ca2+ current flowing around the resting membrane potential of normal parathyroid cells may contribute to [Ca2+]o-activated Ca2+ entry. Regardless, there is no doubt that CaR is necessary in this process, since type II calcimimetic compounds, such as NPS R-568 and AMG 073 (cinacalcet HCl), potentiate the effects of [Ca2+]o on [Ca2+]I and PTH secretion in the presence of extracellular Ca2+ [26, 27]. Because CaR expression is downregulated in hyperparathyroidism [28, 29], Ca2+ entry that is not associated with CaR might play an important role in reducing PTH secretion in hyperparathyroidism.

Regardless of the mechanism through which dihydropyridine-sensitive Ca2+ entry is activated under physiological conditions, our study provides evidence that normal parathyroid cells express a pathway for extracellular Ca2+ entry. This may provide a compensatory mechanism for the negative feedback regulation of PTH secretion under physiological conditions, as well as pathophysiological conditions.

References

  1. Brown EM (1991) Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol Rev 71:371–411

    PubMed  CAS  Google Scholar 

  2. Brown EM, MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81:239–297

    PubMed  CAS  Google Scholar 

  3. Shoback DM, Thather J, Leombruno R, Brown EM (1984) Relationship between parathyroid hormone secretion and cytosolic calcium concentration in dispersed bovine parathyroid cells. Proc Natl Acad Sci USA 81:3113–3117

    Article  PubMed  CAS  Google Scholar 

  4. Nemeth EF, Scarpa A (1986) Cytosolic Ca2+ and the regulation of secretion in parathyroid cells. FEBS Lett 203:3817–3821

    Article  Google Scholar 

  5. Brown EM, Gamba G, Riccardi D, Lombardi M, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC (1993) Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature 366:575–580

    Article  PubMed  CAS  Google Scholar 

  6. Garret JE, Capuano IV, Hammerland LG, Hung BCP, Brown EM, Hebert SC, Nemeth EF, Fuller F (1995) Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270:12919–12925

    Article  Google Scholar 

  7. Kifor O, Diaz R, Butters R, Brown EM (1997) The Ca2+-sensing receptor (CaR) activates phospholipases C, A2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells. J Bone Miner Res 12:715–725

    Article  PubMed  CAS  Google Scholar 

  8. Fitzpatrick LA, Brandi ML, Aurbach GD (1986) Control of PTH secretion is mediated through calcium channels and is blocked by pertussis toxin treatment of parathyroid cells. Biochem Biophys Res Commun 138:960–965

    Article  PubMed  CAS  Google Scholar 

  9. Bogin E (1987) Effect of verapamil on plasma parathyroid hormone. J Clin Chem Clin Biochem 25:83–85

    PubMed  CAS  Google Scholar 

  10. Fitzpatrick LA, Chin H, Nirenberg M, Aurbach GD (1988) Antibodies to an alpha subunit of skeletal muscle calcium channels regulate parathyroid cell secretion. Proc Natl Acad Sci USA 85:2115–2119

    Article  PubMed  CAS  Google Scholar 

  11. Pocotte SL, Ehrenstein G, Fitzpatrick LA (1995) Role of calcium channels in parathyroid hormone secretion. Bone 16:3655–3725

    Google Scholar 

  12. Wynne AG, Romanski SA, Klee GG, Ory SJ, O’Fallon WM, Fitzpatrick LA (1995) Nifedipine, but not verapamil, acutely elevates parathyroid hormone levels in premenopausal women. Clin Endocrinol 42:9–15

    Article  CAS  Google Scholar 

  13. Chang W, Chen T-H, Gardner P, Shoback D (1995) Regulation of Ca2+-conducting currents in parathyroid cells by extracellular Ca2+ and channel blockers. Am J Physiol Endocrinol Metab 269:E864–E877

    CAS  Google Scholar 

  14. Ridefelt P, Hellman P, Rastad J, Larsson R, Akerstroem G, Gylfe E (1996) Effects of calcium channel modulators on the regulation of cytoplasmic Ca2+ and hormone secretion of parathyroid cells. Pharmacol Toxicol 78:147–153

    Article  PubMed  CAS  Google Scholar 

  15. Chang W, Pratt SA, Chen T-H, Tu C-L, Mikala G, Schwartz A, Shoback D (2001) Parathyroid cells express dihydropyridine-sensitive cation currents and L-type calcium channel subunits. Am J Physiol Endocrinol Metab 281:E180–E189

    PubMed  CAS  Google Scholar 

  16. Yokoyama K, Matsuba D, Adachi-Akahane S, Takeyama H, Tabei I, Suzuki A, Shibasaki T, Iida R, Ohkido I, Hosoya T, Suda N (2009) Dihydropyridine- and voltage-sensitive Ca2+ entry in human parathyroid cells. Exp Physiol 94:847–855

    Article  PubMed  CAS  Google Scholar 

  17. Bean BP (1984) Nitrendipine block of cardiac calcium channels: high affinity binding to the inactivated state. Proc Natl Acad Sci USA 81:6388–6392

    Article  PubMed  CAS  Google Scholar 

  18. Sanguinetti MC, Kass RS (1984) Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res 55:336–348

    Article  PubMed  CAS  Google Scholar 

  19. Rampe D, Lacerda AE (1991) A new site for the activation of cardiac calcium channels defined by the nondihydropyridine FPL-64176. J Pharmacol Exp Ther 259:982–987

    PubMed  CAS  Google Scholar 

  20. Yamaguchi S, Zhorov BS, Yoshioka K, Nagao T, Ichijo H, Adachi-Akahane S (2003) Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (Cav1.2) in binding of dihydropyridines and action of Ca2+ channel agonists. Mol Pharmacol 64:235–248

    Article  PubMed  CAS  Google Scholar 

  21. Bruce BR, Anderson NC (1979) Hyperpolarization in mouse parathyroid cells by low calcium. Am J Physiol Cell Physiol 236:C15–C21

    CAS  Google Scholar 

  22. Loepez-Barneo J, Armstrong CM (1983) Depolarizing response of rat parathyroid cells to divalent cations. J Gen Physiol 82:269–294

    Article  Google Scholar 

  23. Komwatana P, Conigrave AD, Delbridge L, Young JA, Cook DI (1994) Intracellular Ca2+ inactivates an outwardly rectifying K+ current in human adenomatous parathyroid cells. Pflugers Arch 426:320–327

    Article  PubMed  CAS  Google Scholar 

  24. Vassilev PM, Kanazirska C, Ye C, Francis J, Hong K, Brown EM (1997) A flickery block of a K+ channel mediated by extracellular Ca2+ and other agonists of the Ca2+-sensing receptors in dispersed bovine parathyroid cells. Biochem Biophys Res Commun 230:616–623

    Article  PubMed  CAS  Google Scholar 

  25. Kanazirska MPV, Vassilev PM, Ye CP, Francis IE, Brown EM (1995) Intracellular Ca2+-activated K+ channels modulated by variations in extracellular Ca2+ in dispersed bovine parathyroid cells. Endocrinology 136:2238–2243

    Article  PubMed  CAS  Google Scholar 

  26. Nemeth EF, Steffey ME, Hammerland LG, Hung BCP, Van Wagenen BC, Delmar EG, Balandrin MF (1998) Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 95:4040–4045

    Article  PubMed  CAS  Google Scholar 

  27. Nemeth EF, Heaton WH, Miller M, Fox J, Balandrin MF, Van Wagenen BC, Colloton M, Karbon W, Scherrer J, Shatzen E, Rishton G, Scully S, Qi M, Harris R, Lacey D, Martin D (2004) Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther 308:627–635

    Article  PubMed  CAS  Google Scholar 

  28. Kifor O, Moore FD, Wang JRP, Goldstein M, Vassilev P, Kifor I, Hebert SC, Brown EM (1996) Reduced immunostaining for the extracellular Ca-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598–1606

    Article  PubMed  CAS  Google Scholar 

  29. Yano S, Sugimoto T, Tsukamoto T, Chihara K, Kobayashi A, Kitazawa S, Maeda S, Kitazawa R (2000) Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 58:1980–1986

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful to Professor Satoshi Kurihara for his continuous encouragement and to Naoko Tomizawa for her excellent technical assistance. This work was supported by Grants-in-Aid for Scientific Research and for Scientific Research on Priority Areas from the Ministry of Education, Science and Culture of Japan; and by the Jikei University Research Fund. D.M. was supported by an Ishidsu Shun Memorial Scholarship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rinako Iida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iida, R., Yokoyama, K., Ohkido, I. et al. Detection of dihydropyridine- and voltage-sensitive intracellular Ca2+ signals in normal human parathyroid cells. J Physiol Sci 63, 235–240 (2013). https://doi.org/10.1007/s12576-013-0255-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12576-013-0255-x

Keywords